Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 24 May 2023

SIRT1 mediated gastric cancer progression under glucose deprivation through the FoxO1-Rab7-autophagy axis

in Molecular and Cellular Oncology

Mengke Zhu
Chao Wei
Haijiang Wang
Shangning Han
Lindi Cai
Xiaowen Li
Xinhua Liao
Xiangming Che
Xuqi Li
Lin Fan

Frontiers in Oncology

doi 10.3389/fonc.2023.1175151

3,367 views
12 citations

Correction

Published on 22 May 2023

Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1

in Molecular and Cellular Oncology

Wentao Zhang
Shiyu Mao
Donghui Shi
Junfeng Zhang
Ziwei Zhang
Yadong Guo
Yuan Wu
Ruiliang Wang
Longsheng Wang
Yong Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1208728

1,313 views

Review

Published on 22 May 2023

Cancer immune exclusion: breaking the barricade for a successful immunotherapy

in Molecular and Cellular Oncology

Sofia Bruni
María Florencia Mercogliano
Florencia Luciana Mauro
Rosalia Inés Cordo Russo
Roxana Schillaci

Frontiers in Oncology

doi 10.3389/fonc.2023.1135456

10,943 views
13 citations

Review

Published on 19 May 2023

Characterization of LIMA1 and its emerging roles and potential therapeutic prospects in cancers

in Molecular and Cellular Oncology

Xiaoxiao Wang
Chao Zhang
Huangqin Song
Junlong Yuan
Xiaomin Zhang
Yiran Yuan
Lei Zhang
Jiefeng He

Frontiers in Oncology

doi 10.3389/fonc.2023.1115943

5,410 views
10 citations

Original Research

Published on 19 May 2023

Ubiquitination-related biomarkers in metastatic melanoma patients and their roles in tumor microenvironment

in Molecular and Cellular Oncology

Li Zhang
Zhehao Shi
Fan Zhang
Bin Chen
Wei Qiu
Lei Cai
Xiaohua Lin

Frontiers in Oncology

doi 10.3389/fonc.2023.1170190

2,260 views
3 citations

Original Research

Published on 18 May 2023

Identification of key immune genes related to lymphatic metastasis of papillary thyroid cancer via bioinformatics analysis and experimental validation

in Molecular and Cellular Oncology

Yang Yu
Xing Guo
Jian Chai
Zhuoyi Han
Yaming Ji
Jirui Sun
Huiqing Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1181325

2,916 views
3 citations

Mini Review

Published on 18 May 2023

Metastasis in neuroblastoma: the MYCN question

in Molecular and Cellular Oncology

Swapnil Parashram Bhavsar

Frontiers in Oncology

doi 10.3389/fonc.2023.1196861

3,425 views
5 citations

Review

Published on 17 May 2023

The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity

in Molecular and Cellular Oncology

Vincenzo Salemme
Giorgia Centonze
Lidia Avalle
Dora Natalini
Alessio Piccolantonio
Pietro Arina
Alessandro Morellato
Ugo Ala
Daniela Taverna
Emilia Turco

Frontiers in Oncology

doi 10.3389/fonc.2023.1170264

9,789 views
45 citations

Editorial

Published on 16 May 2023

Editorial: Case reports in molecular and cellular oncology: 2022

in Molecular and Cellular Oncology

Shuhua Zheng
Tarita O. Thomas

Frontiers in Oncology

doi 10.3389/fonc.2023.1209048

1,397 views

Original Research

Published on 12 May 2023

Comprehensive analysis and molecular map of Hippo signaling pathway in lower grade glioma: the perspective toward immune microenvironment and prognosis

in Molecular and Cellular Oncology

Yu-Duo Guo
Jie Sun
Chao Zhao
Le Han
Chun-Jiang Yu
Hong-Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1198414

2,718 views
1 citation

Original Research

Published on 10 May 2023

Austrian tricentric real-life analysis of molecular profiles of metastatic biliary tract cancer patients

in Molecular and Cellular Oncology

Hossein Taghizadeh
Theresa Schmalfuss
Agnieszka Maj-Hes
Josef Singer
Gerald W. Prager

Frontiers in Oncology

doi 10.3389/fonc.2023.1143825

2,381 views
1 citation

Brief Research Report

Published on 10 May 2023

FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer–gene programs in basal-like breast cancer

in Molecular and Cellular Oncology

Kohei Kumegawa
Liying Yang
Kenichi Miyata
Reo Maruyama

Frontiers in Oncology

doi 10.3389/fonc.2023.1156111

2,196 views
7 citations

Mini Review

Published on 10 May 2023

Regulation of tumor angiogenesis by the crosstalk between innate immunity and endothelial cells

in Molecular and Cellular Oncology

Svenja Ebeling
Anita Kowalczyk
Diego Perez-Vazquez
Irene Mattiola

Frontiers in Oncology

doi 10.3389/fonc.2023.1171794

4,180 views
17 citations

Original Research

Published on 09 May 2023

Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated epithelial-to-mesenchymal transition

in Molecular and Cellular Oncology

Enrico Capobianco
Vanessa McGaughey
Gerbenn Seraphin
John Heckel
Sandra Rieger
Thomas S. Lisse

Frontiers in Oncology

doi 10.3389/fonc.2023.1188641

4,642 views
9 citations

Case Report

Published on 08 May 2023

Case Report: Lung adenocarcinoma associated with germline ERCC2 frameshift mutation

in Molecular and Cellular Oncology

Lili Liu
Jia Cui
Siye Liu
Evenki Pan
Limin Sun

Frontiers in Oncology

doi 10.3389/fonc.2023.1177942

2,182 views
2 citations

Mini Review

Published on 08 May 2023

MAP4K4 and cancer: ready for the main stage?

in Molecular and Cellular Oncology

Jaime González-Montero
Carlos I. Rojas
Mauricio Burotto

Frontiers in Oncology

doi 10.3389/fonc.2023.1162835

4,517 views
7 citations